Responding to removal of its Medicare “deemed status,” MD Anderson Cancer Center has submitted a “plan of correction” to the Texas Health and Human Services Commission to demonstrate that it is now in compliance with all federal requirements for participation in the Medicare program.
In his new book, “No More Tears: The Dark Secrets of Johnson & Johnson,” Gardiner Harris, who was previously the public health and pharmaceutical business reporter for The New York Times, talks about the history of the overuse of red blood cell growth factors in oncology.
